Hims & Hers Health (HIMS) fell 4.32% to $17.73, leaving the stock below its 7-, 20- and 50-day moving averages. The latest readout shows oversold momentum and constructive buy-side activity on Bina...
HIMS shares closed at $17.73, down 4.32% on the session, with a 24-hour range of $18.70 to $17.16. That leaves the stock below its 7-day SMA of $18.89, its 20-day SMA of $22.82 and its 50-day SMA of $26.54, a clean bearish alignment that tells you the intermediate trend is still pointed lower.
At the same time, the stock is no longer acting stretched on the downside. The 14-day RSI sits at 28.03, which is in oversold territory, while %B at 0.1526 shows price sitting close to the lower Bollinger Band at $15.50. That does not guarantee a bounce, but it does mean the selloff is approaching levels where mean reversion becomes more plausible.
The key question is whether HIMS can stabilize above the pivot point at $17.86 and defend immediate support at $17.03. If it can, the first test is immediate resistance at $18.57, with stronger resistance at $19.40 beyond that.
If $17.03 fails, the chart opens toward strong support at $16.32. With ATR(14) at $1.92, the stock has enough daily volatility to move through these levels quickly, so traders should treat the nearby support band as a real battleground rather than a soft floor.
The moving-average structure is the main constraint here. A stock can be oversold and still stay weak if the broader trend remains under pressure, and HIMS is still trading well below all major short-term trend gauges.
Source link







